Hakutulokset - David Devos

Tarkenna hakua
  1. 1
    Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease

    Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease Tekijä David Devos

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics

    Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics Tekijä Alexandre Demailly, Caroline Moreau, David Devos

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Seven Solutions for Neuroprotection in Parkinson's Disease

    Seven Solutions for Neuroprotection in Parkinson's Disease Tekijä David Devos, Étienne C. Hirsch, Richard Wyse

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Regional siderosis: a new challenge for iron chelation therapy

    Regional siderosis: a new challenge for iron chelation therapy Tekijä Z. Ioav Cabantchik, Arnold Münnich, Moussa B. H. Youdim, David Devos

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Early occurrence of inspiratory muscle weakness in Parkinson’s disease

    Early occurrence of inspiratory muscle weakness in Parkinson’s disease Tekijä Guillaume Baille, T. Pérez, David Devos, Valérie Deken, Luc Defebvre, Caroline Moreau

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

    Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration Tekijä Shashank Masaldan, Ashley I. Bush, David Devos, Anne‐Sophie Rolland, Caroline Moreau

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates

    Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates Tekijä Flore Gouel, Anne‐Sophie Rolland, Jean‐Christophe Devedjian, Thierry Burnouf, David Devos

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation

    Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation Tekijä David Devos, P. Jissendi Tchofo, I. Vuillaume, A. Destée, S. Batey, John Burn, Patrick F. Chinnery

    Julkaistu 2008
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Dyspnea: An underestimated symptom in Parkinson's disease

    Dyspnea: An underestimated symptom in Parkinson's disease Tekijä Guillaume Baille, Cécile Chenivesse, T. Pérez, François Machuron, Kathy Dujardin, David Devos, Luc Defebvre, Caroline Moreau

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

    Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease Tekijä Laura Mahoney-Sánchez, Hind Bouchaoui, Scott Ayton, David Devos, James A. Duce, Jean-Christophe Devedjian

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease

    Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease Tekijä James A. Duce, Bruce X. Wong, Hannah Durham, Jean-Christophe Devedjian, David P. Smith, David Devos

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Glycosphingolipids and neuroinflammation in Parkinson’s disease

    Glycosphingolipids and neuroinflammation in Parkinson’s disease Tekijä Karim Bélarbi, Elodie Cuvelier, Marie-Amandine Bonte, Mazarine Desplanque, Bernard Gressier, David Devos, Marie‐Christine Chartier‐Harlin

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Ventilatory Dysfunction in Parkinson’s Disease

    Ventilatory Dysfunction in Parkinson’s Disease Tekijä Guillaume Baille, Anna Maria De Jesus, T. Pérez, David Devos, Kathy Dujardin, C. Monaca Charley, Luc Defebvre, Caroline Moreau

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons

    ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons Tekijä Hind Bouchaoui, Laura Mahoney-Sánchez, Guillaume Garçon, Olivier Berdeaux, L. Alleman, David Devos, James A. Duce, Jean-Christophe Devedjian

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study

    Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study Tekijä Hélène Blasco, Guillaume Garçon, Franck Patin, Charlotte Veyrat‐Durebex, Judith Boyer, David Devos, Patrick Vourc’h, Christian Andrés, Philippe Corcia

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review

    The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review Tekijä Guillaume Grolez, Caroline Moreau, Véronique Danel-Brunaud, Christine Delmaire, Renaud Lopes, Pierre Pradat, Mohamed Mounir El Mendili, Luc Defebvre, David Devos

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways

    The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways Tekijä Flore Gouel, Bruce Do Van, Ming‐Li Chou, Aurélie Jonneaux, Caroline Moreau, Régis Bordet, Thierry Burnouf, Jean‐Christophe Devedjian, David Devos

    Julkaistu 2016
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Iron as a therapeutic target for Parkinson's disease

    Iron as a therapeutic target for Parkinson's disease Tekijä Caroline Moreau, James A. Duce, Olivier Rascol, Jean‐Christophe Devedjian, Daniela Berg, David T. Dexter, Zvi-Ioav Cabantchik, Ashley I. Bush, David Devos

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Exhaustive, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS

    Exhaustive, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS Tekijä Mélissa Tir, David Devos, S. Blond, Gustavo Touzet, Nicolas Reyns, Alain Duhamel, Olivier Cottencin, Kathy Dujardin, F. Cassim, A. Destée, Luc Defebvre, Pierre Krystkowiak

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease Tekijä Per Odin, К. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: